UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 84 filers reported holding UROGEN PHARMA LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $1,568,000 | -72.2% | 180,000 | -69.7% | 0.08% | -76.0% |
Q4 2021 | $5,646,000 | -53.6% | 593,656 | -18.0% | 0.33% | -53.2% |
Q3 2021 | $12,172,000 | +10.3% | 723,677 | +0.1% | 0.70% | +1.2% |
Q2 2021 | $11,038,000 | +9.6% | 722,875 | +39.8% | 0.70% | -1.0% |
Q1 2021 | $10,073,000 | – | 517,106 | – | 0.70% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Horton Capital Management, LLC | 684,749 | $11,517,000 | 23.27% |
GREAT POINT PARTNERS LLC | 750,000 | $12,615,000 | 2.94% |
HealthInvest Partners AB | 75,000 | $1,262,000 | 1.89% |
Wildcat Capital Management, LLC | 533,139 | $8,967,000 | 1.16% |
Annandale Capital, LLC | 86,254 | $1,451,000 | 0.87% |
MENORA MIVTACHIM HOLDINGS LTD. | 2,954,699 | $49,698,000 | 0.73% |
ZEKE CAPITAL ADVISORS, LLC | 723,677 | $12,172,000 | 0.70% |
Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 25,330 | $426,000 | 0.34% |
RTW INVESTMENTS, LP | 857,464 | $14,423,000 | 0.22% |
SHIKIAR ASSET MANAGEMENT INC | 33,350 | $561,000 | 0.16% |